MarketCap
Facebook
X
TelegramAnnual report 2024
added 01-10-2026
ICON Public Limited Company Total Shareholders Equity 2011-2026 | ICLR
Annual Total Shareholders Equity ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.52 B | 9.24 B | 8.5 B | 8.07 B | 1.85 B | 1.62 B | 1.35 B | 1.19 B | 945 M | 763 M | 950 M | 911 M | 755 M | 682 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.52 B | 682 M | 3.31 B |
Quarterly Total Shareholders Equity ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 8.07 B | 8.07 B | 7.97 B | 2.03 B | 1.93 B | 1.85 B | 1.71 B | 1.58 B | 1.51 B | 1.62 B | 1.5 B | 1.5 B | 1.42 B | 1.35 B | 1.33 B | 1.24 B | 1.2 B | 1.19 B | 1.13 B | 1.03 B | 945 M | 945 M | 992 M | 910 M | 844 M | 763 M | 863 M | 1.02 B | 999 M | 950 M | 1.01 B | 998 M | 961 M | 911 M | 855 M | 802 M | 768 M | 755 M | 719 M | 684 M | 702 M | 682 M | 697 M | 712 M | 693 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.07 B | 682 M | 1.56 B |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Anixa Biosciences
ANIX
|
15.2 M | $ 3.11 | -2.51 % | $ 101 K |  USA |
|
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Brainsway Ltd.
BWAY
|
19.6 M | $ 22.32 | -3.71 % | $ 99.4 M |  Israel |
 |
BioNano Genomics
BNGO
|
35.4 M | $ 1.45 | -3.67 % | $ 1.84 M | USA |
 |
Aspira Women's Health
AWH
|
6.73 M | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
1.85 B | $ 30.5 | -4.72 % | $ 328 M |  China |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-1.45 M | - | - | $ 9.42 M | Israel |
 |
Castle Biosciences
CSTL
|
456 M | $ 40.78 | 1.92 % | $ 1.13 B | USA |
 |
Co-Diagnostics
CODX
|
86 M | - | - | $ 79.8 M | USA |
 |
DexCom
DXCM
|
2.07 B | $ 70.44 | 1.29 % | $ 27.2 B | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Guardant Health
GH
|
-140 M | $ 113.62 | 1.32 % | $ 13.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 147.36 | 4.03 % | $ 23.4 B | USA |
 |
CareDx, Inc
CDNA
|
261 M | $ 20.08 | 0.35 % | $ 1.08 B | USA |
 |
Danaher Corporation
DHR
|
49.5 B | $ 234.95 | -0.44 % | $ 172 B | USA |
 |
Celcuity
CELC
|
116 M | $ 105.63 | -1.25 % | $ 4.17 B | USA |
 |
DarioHealth Corp.
DRIO
|
58.1 M | $ 12.48 | 0.28 % | $ 354 M | Israel |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 27.65 | -1.53 % | $ 836 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | $ 102.21 | -0.22 % | $ 18.9 B | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 66.02 | 2.75 % | $ 4.57 B | USA |
 |
Medpace Holdings
MEDP
|
826 M | $ 602.32 | -1.41 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
6.07 B | $ 234.18 | -1.47 % | $ 42.5 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.57 B | - | - | $ 10.6 B |  Niderland |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.28 | 0.27 % | $ 2.01 B | USA |
 |
National Research Corporation
NRC
|
49 M | $ 22.06 | -0.72 % | $ 541 M | USA |
 |
Charles River Laboratories International
CRL
|
3.46 B | $ 219.04 | -0.3 % | $ 11.3 B | USA |
 |
OPKO Health
OPK
|
1.37 B | $ 1.3 | 1.56 % | $ 902 M | USA |
 |
Pacific Biosciences of California
PACB
|
701 M | $ 2.36 | 6.79 % | $ 599 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.78 B | $ 188.87 | -0.33 % | $ 21 B | USA |
|
Biodesix
BDSX
|
20.9 M | $ 8.85 | 12.25 % | $ 1.15 B | USA |
 |
Mettler-Toledo International
MTD
|
-127 M | $ 1 409.56 | -3.5 % | $ 29.9 B |  Schweiz |
 |
Laboratory Corporation of America Holdings
LH
|
8.05 B | $ 272.02 | 0.42 % | $ 22.8 B | USA |
 |
IDEXX Laboratories
IDXX
|
1.6 B | $ 688.67 | -3.73 % | $ 56.8 B | USA |
 |
Myriad Genetics
MYGN
|
701 M | $ 5.65 | -4.56 % | $ 512 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.56 M | $ 4.67 | -2.3 % | $ 2.51 M | USA |
 |
Agilent Technologies
A
|
5.39 B | $ 135.52 | -2.95 % | $ 41.2 B | USA |